{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:25:00Z","timestamp":1794018300056,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humpath.2026.106214","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:21:27Z","timestamp":1784071287000},"page":"106214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+\/HER2\u2212 breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-2148","authenticated-orcid":false,"given":"Zohre","family":"Sadeghian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rhode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alhalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvia","family":"Goez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Nahleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-3988","authenticated-orcid":false,"given":"Esther","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106214_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221081077","article-title":"Oncotype DX recurrence score in premenopausal women","volume":"14","author":"Zhang","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"16","key":"10.1016\/j.humpath.2026.106214_bib2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.22.00069","article-title":"Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update","volume":"40","author":"Andre","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106214_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.humpath.2026.106214_bib4","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.humpath.2026.106214_bib5","first-page":"290","article-title":"Breast cancer\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA: a cancer J for clinicians"},{"issue":"5","key":"10.1016\/j.humpath.2026.106214_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/tbj.13352","article-title":"Impact of biomarkers and genetic profiling on breast cancer prognostication: a comparative analysis of the 8th edition of breast cancer staging system","volume":"25","author":"Yoon","year":"2019","journal-title":"Breast J"},{"issue":"Supplement 1","key":"10.1016\/j.humpath.2026.106214_bib7","article-title":"Comparison of the distribution of oncotype Dx recurrence scores between invasive ductal carcinoma and invasive lobular carcinoma of the breast","volume":"1","author":"Yadav","year":"2021","journal-title":"Int J Cancer Care and Delivery"},{"key":"10.1016\/j.humpath.2026.106214_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-017-4619-4","article-title":"Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results","volume":"168","author":"Singh","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2026.106214_bib9","first-page":"1546","article-title":"Comparison of Oncotype DX recurrence score by histologic types of breast carcinoma","author":"Bomeisl","year":"2015","journal-title":"The College of American Pathologists"},{"issue":"11","key":"10.1016\/j.humpath.2026.106214_bib10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.5858\/arpa.2016-0195-LE","article-title":"To oncotype or not: knowledge of histologic grade and subtype may help","volume":"140","author":"Kalife","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.humpath.2026.106214_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.5858\/arpa.2023-0950-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical oncology\u2013college of American pathologists guideline update","volume":"147","author":"Wolff","year":"2023","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.humpath.2026.106214_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5858\/arpa.2019-0904-SA","article-title":"Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology\/college of American pathologists guideline update","volume":"144","author":"Allison","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106214_bib13","volume":"vol 1024","author":"Amin","year":"2017"},{"issue":"1","key":"10.1016\/j.humpath.2026.106214_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41523-021-00368-9","article-title":"The 21-gene recurrence score in early non-ductal breast cancer: a national cancer database analysis","volume":"8","author":"Makower","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.humpath.2026.106214_bib15","series-title":"Seminars in diagnostic pathology","article-title":"Lobular breast carcinoma and its variants","author":"Rakha","year":"2010"},{"issue":"9","key":"10.1016\/j.humpath.2026.106214_bib16","article-title":"Invasive lobular carcinoma of the breast: a special histological type compared with invasive ductal carcinoma","volume":"12","author":"Chen","year":"2017","journal-title":"Diagn Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106214_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3109\/07357907.2010.496754","article-title":"A lower allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer","volume":"28","author":"Tang","year":"2010","journal-title":"Cancer Invest"},{"issue":"3","key":"10.1016\/j.humpath.2026.106214_bib18","doi-asserted-by":"crossref","first-page":"zrab040","DOI":"10.1093\/bjsopen\/zrab040","article-title":"The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer","volume":"5","author":"Davey","year":"2021","journal-title":"BJS Open"},{"key":"10.1016\/j.humpath.2026.106214_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102387","article-title":"Research progress on estrogen receptor-positive\/progesterone receptor-negative breast cancer","volume":"56","author":"Lu","year":"2025","journal-title":"Transl Oncol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106214_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/bjc.2011.402","article-title":"Ki 67 is a major, but not the sole determinant of oncotype Dx recurrence score","volume":"105","author":"Sahebjam","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2026.106214_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1634\/theoncologist.7-3-246","article-title":"Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials","volume":"7","author":"Mincey","year":"2002","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.humpath.2026.106214_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10549-025-07661-2","article-title":"Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: a single-institution experience","volume":"211","author":"Han","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.humpath.2026.106214_bib23","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/s41467-025-57283-x","article-title":"Multimodal histopathologic models stratify hormone receptor-positive early breast cancer","volume":"16","author":"Boehm","year":"2025","journal-title":"Nat Commun"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:43:34Z","timestamp":1794015814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"alternative-id":["S0046817726001838"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106214","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+\/HER2\u2212 breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106214"}}